Ghassan Abou-Alfa, MD | Authors


Current Agents Approved for Treatment of HCC

November 15, 2018

Ghassan Abou-Alfa, MD, discusses the approved agents available for the treatment of hepatocellular carcinoma. Compared to 2007 when there was only 1 agent available, sorafenib, there is now a great number of options for these patients.